Delivery Order SPE2DE24D0013-SPE2D625F6NS8

The U.S. Defense Department's Medical Supply Chain agency awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. on July 14, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, which is due for completion by July 21, 2025, utilizes no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. This delivery order represents a continuation of Cepheid's established role as a primary supplier of molecular diagnostic equipment and testing reagents to federal health agencies.

This award is likely issued under one of Cepheid's existing indefinite delivery vehicles with the Veterans Affairs system, which provide the contractual framework for ordering diagnostic testing solutions. Cepheid specializes in GeneXpert diagnostic systems and associated test kits for infectious diseases, with a proven track record of supporting VA healthcare networks, the Defense Logistics Agency, and the Defense Health Agency. The company's federal contracts have historically ranged from thousands to nearly $1 million in value, with the larger IDV contracts valued at $32.8 million and $2.5 million respectively, demonstrating Cepheid's significant presence in the federal molecular diagnostics marketplace.